Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael G Fehlings

Showing results (11-20 of 1,088) with videos related to

Pageof 109
Sort By:
Neurospine|January 7, 2020
Acidic Fibroblast Growth Factor in Spinal Cord Injury: A Potential Therapy Which Merits Further InvestigationKazuya Yokota, Michael G Fehlings
Journal of Neurosurgery|October 18, 2003
Clinical and radiological evaluation of the Codman semiconstrained load-sharing anterior cervical plate: prospective multicenter trial and independent blinded evaluation of outcomeSteven Casha, Michael G Fehlings
Journal of Neurotrauma|March 15, 2002
Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 1. Clip design, behavioral outcomes, and histopathologyMital Joshi, Michael G Fehlings
Journal of Neurosurgery. Spine|November 26, 2009
Factors predicting the resectability of intramedullary spinal cord tumors and the progression-free survival following microsurgical treatmentMichael G Fehlings, David Mercier
Journal of Neurosurgery. Spine|September 23, 2009
Surgical management of cervical degenerative disease: the evidence related to indications, impact, and outcomeMichael G Fehlings, Babak Arvin
Journal of Neurosurgery. Spine|October 5, 2010
En bloc resection for metastatic spinal tumors: is it worth it?Michael G Fehlings, Doron Rabin
World Neurosurgery|January 10, 2013
Rho-ROCK inhibition in the treatment of spinal cord injuryNicole Forgione, Michael G Fehlings
Current Stem Cell Research & Therapy|December 29, 2012
Mesenchymal cells in the treatment of spinal cord injury: current & future perspectivesReaz Vawda, Michael G Fehlings
Stem Cells Translational Medicine|March 9, 2023
Incorporating Combinatorial Approaches to Encourage Targeted Neural Stem/Progenitor Cell Integration Following Transplantation in Spinal Cord InjuryKatarzyna Pieczonka, Michael G Fehlings
Expert Opinion on Investigational Drugs|February 4, 2015
Investigational drugs for the treatment of spinal cord injury: review of preclinical studies and evaluation of clinical trials from Phase I to IINarihito Nagoshi, Michael G Fehlings
Pageof 109

Showing results (11-20 of 1,088) with videos related to

Sort By:
Pageof 109
Neurospine|January 7, 2020
Acidic Fibroblast Growth Factor in Spinal Cord Injury: A Potential Therapy Which Merits Further InvestigationKazuya Yokota, Michael G Fehlings
Journal of Neurosurgery|October 18, 2003
Clinical and radiological evaluation of the Codman semiconstrained load-sharing anterior cervical plate: prospective multicenter trial and independent blinded evaluation of outcomeSteven Casha, Michael G Fehlings
Journal of Neurotrauma|March 15, 2002
Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 1. Clip design, behavioral outcomes, and histopathologyMital Joshi, Michael G Fehlings
Journal of Neurosurgery. Spine|November 26, 2009
Factors predicting the resectability of intramedullary spinal cord tumors and the progression-free survival following microsurgical treatmentMichael G Fehlings, David Mercier
Journal of Neurosurgery. Spine|September 23, 2009
Surgical management of cervical degenerative disease: the evidence related to indications, impact, and outcomeMichael G Fehlings, Babak Arvin
Journal of Neurosurgery. Spine|October 5, 2010
En bloc resection for metastatic spinal tumors: is it worth it?Michael G Fehlings, Doron Rabin
World Neurosurgery|January 10, 2013
Rho-ROCK inhibition in the treatment of spinal cord injuryNicole Forgione, Michael G Fehlings
Current Stem Cell Research & Therapy|December 29, 2012
Mesenchymal cells in the treatment of spinal cord injury: current & future perspectivesReaz Vawda, Michael G Fehlings
Stem Cells Translational Medicine|March 9, 2023
Incorporating Combinatorial Approaches to Encourage Targeted Neural Stem/Progenitor Cell Integration Following Transplantation in Spinal Cord InjuryKatarzyna Pieczonka, Michael G Fehlings
Expert Opinion on Investigational Drugs|February 4, 2015
Investigational drugs for the treatment of spinal cord injury: review of preclinical studies and evaluation of clinical trials from Phase I to IINarihito Nagoshi, Michael G Fehlings
Pageof 109